Table 4.
Paper | PPD > 3 mm | PPD > 5 mm | ||
---|---|---|---|---|
Test (AB type = 1) | Control (AB type = 0) | Test (AB type = 1) | Control (AB type = 0) | |
a) At 3 months follow up | ||||
Aimetti [36] | 37 | 70 | 0 | 0 |
Cionca [29] | 52 | 75 | 0 | 0 |
Feres 2012 [41] | 26 | 55 | 0 | 0 |
Heller [45] | 83 | 100 | 0 | 0 |
Matarazzo [40] | 50 | 73 | 0 | 0 |
Mestnik [37, 53] | 27 | 60 | 0 | 0 |
Mombelli [24] Aac+ | 36 | 58 | 0 | 5 |
Mombelli [24] Aac- | 54 | 63 | 0 | 5 |
Preus 2013 [99], FMDIS | 0 | 0 | 0 | 0 |
Preus 2013 [99], SRP | 0 | 26 | 0 | 0 |
b) At 6 months follow up | ||||
Aimetti [36] | 32 | 65 | 0 | 0 |
Cionca [29] | 42 | 63 | 0 | 0 |
Feres 2012 [41] | 15 | 53 | 0 | 0 |
Heller [45] | 17 | 100 | 0 | 0 |
Mestnik [37, 50] | 13 | 60 | 0 | 0 |
Winkel [49] | 52 | 76 | 0 | 0 |
Xajigeorgiou [50] | 60 | 72 | 0 | 0 |
AB type 1 – systemic antibiotic administration.
AB type 0 – no antibiotic administration.
Aac + - Regarding Evaluation from subgroup positiv for A. actinomycetemcomitans.
Aac- - Regarding Evaluation from subgroup negative for A. actinomycetemcomitans.